These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15911360)

  • 1. Lamotrigine therapy in patients requiring a change in antiepileptic drug regimen.
    Kustra RP; Meador KJ; Evans BK; Leschek-Gelman LM; Groenke DA; Hammer AE; Nanry KP; Messenheimer JA;
    Seizure; 2005 Jun; 14(4):254-61. PubMed ID: 15911360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of tolerability in elderly patients: changing to lamotrigine therapy.
    Evans BK; Kustra RP; Hammer AE
    Am J Geriatr Pharmacother; 2007 Jun; 5(2):112-9. PubMed ID: 17719513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dosing algorithm for converting from valproate monotherapy to lamotrigine monotherapy in patients with epilepsy.
    Sale ME; Natarajan S; Biton V; Vuong A; Hammer AE; Messenheimer JA; Blum D
    Epilepsy Behav; 2005 Feb; 6(1):63-70. PubMed ID: 15652736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lamotrigine extended-release as adjunctive therapy with optional conversion to monotherapy in older adults with epilepsy.
    Wechsler RT; Leroy R; Van Cott A; Hammer AE; Vuong A; Huffman R; VanLandingham K; Messenheimer JA
    Epilepsy Res; 2014 Aug; 108(6):1128-36. PubMed ID: 24888248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lamotrigine monotherapy compared with carbamazepine, phenytoin, or valproate monotherapy in patients with epilepsy.
    Kaminow L; Schimschock JR; Hammer AE; Vuong A
    Epilepsy Behav; 2003 Dec; 4(6):659-66. PubMed ID: 14698699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of adjunctive lamotrigine for refractory epilepsy in institutional or community residents with mental retardation.
    Sunder TR; McKee JR; Hammer AE; Vuongc A
    Curr Med Res Opin; 2006 Apr; 22(4):693-702. PubMed ID: 16684430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lamotrigine in patients with epilepsy and comorbid depressive symptoms.
    Fakhoury TA; Barry JJ; Mitchell Miller J; Hammer AE; Vuong A
    Epilepsy Behav; 2007 Feb; 10(1):155-62. PubMed ID: 17166775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement in quality of life after initiation of lamotrigine therapy in patients with epilepsy in a naturalistic treatment setting.
    Allain H; Schück S; Nachit-Ouinekh F; Plouin P; Brunon AM; Boulliat J; Mercier F; Slama A; Baulac M; El Hasnaoui A
    Seizure; 2007 Mar; 16(2):173-84. PubMed ID: 17208465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Open study evaluating lamotrigine efficacy and safety in add-on treatment and consecutive monotherapy in patients with carbamazepine- or valproate-resistant epilepsy.
    Jozwiak S; Terczynski A
    Seizure; 2000 Oct; 9(7):486-92. PubMed ID: 11034873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of conversion to monotherapy with lamotrigine compared with valproate and carbamazepine in patients with epilepsy.
    Fakhoury TA; Hammer AE; Vuong A; Messenheimer JA
    Epilepsy Behav; 2004 Aug; 5(4):532-8. PubMed ID: 15256191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of lamotrigine on mood in older adults with epilepsy and co-morbid depressive symptoms: an open-label, multicentre, prospective study.
    Fakhoury TA; Miller JM; Hammer AE; Vuong A
    Drugs Aging; 2008; 25(11):955-62. PubMed ID: 18947263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of lamotrigine compared with levetiracetam on anger, hostility, and total mood in patients with partial epilepsy.
    Labiner DM; Ettinger AB; Fakhoury TA; Chung SS; Shneker B; Tatum Iv WO; Mitchell Miller J; Vuong A; Hammer AE; Messenheimer JA
    Epilepsia; 2009 Mar; 50(3):434-42. PubMed ID: 19016830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life and treatment satisfaction in Spanish epilepsy patients on monotherapy with lamotrigine or valproic acid.
    Viteri C; Codina M; Cobaleda S; Lahuerta J; Barriga J; Morales MD;
    Seizure; 2010 Sep; 19(7):432-8. PubMed ID: 20663691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conversion to lamotrigine monotherapy from valproate monotherapy in older adolescent patients with epilepsy.
    Baumann RJ; Fakhoury TA; Kustra RP; Vuong A; Hammer AE; Messenheimer JA
    Curr Med Res Opin; 2007 Oct; 23(10):2461-5. PubMed ID: 17727739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lamotrigine in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP; Vos AM; Hulsman J; Lambrechts D; Leenen L; Majoie M; Savelkoul M; Schellekens A; Aldenkamp AP
    Epilepsy Behav; 2008 Feb; 12(2):262-8. PubMed ID: 18093878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved mood states with lamotrigine in patients with epilepsy.
    Cramer JA; Hammer AE; Kustra RP
    Epilepsy Behav; 2004 Oct; 5(5):702-7. PubMed ID: 15380122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The longer-term cognitive effects of adjunctive antiepileptic treatment with lacosamide in comparison with lamotrigine and topiramate in a naturalistic outpatient setting.
    Helmstaedter C; Witt JA
    Epilepsy Behav; 2013 Feb; 26(2):182-7. PubMed ID: 23318473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjunctive lamotrigine for partial seizures in patients aged 1 to 24 months.
    Piña-Garza JE; Levisohn P; Gucuyener K; Mikati MA; Warnock CR; Conklin HS; Messenheimer J
    Neurology; 2008 May; 70(22 Pt 2):2099-108. PubMed ID: 18077797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term tolerability and efficacy of lamotrigine in infants 1 to 24 months old.
    Piña-Garza JE; Elterman RD; Ayala R; Corral M; Mikati MA; Piña-Garza MJ; Warnock CR; Conklin HS; Messenheimer JA
    J Child Neurol; 2008 Aug; 23(8):853-61. PubMed ID: 18660469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.